
TY  - JOUR
TI  - 2016 ACR/ARHP Annual Meeting Abstract Supplement
JO  - Arthritis & Rheumatology
JA  - Arthritis & Rheumatology
VL  - 68
IS  - S10
SN  - 2326-5191
UR  - https://doi.org/10.1002/art.39977
DO  - doi:10.1002/art.39977
SP  - 1
EP  - 4550
PY  - 2016
AB  - For a searchable version of these abstracts, please visit www.acrabstracts.org.
ER  - 

TY  - JOUR
TI  - Abstracts Published Only
JO  - Journal of Digestive Diseases
JA  - Journal of Digestive Diseases
VL  - 19
IS  - S1
SN  - 1751-2972
UR  - https://doi.org/10.1111/1751-2980.12665
DO  - doi:10.1111/1751-2980.12665
SP  - 49
EP  - 146
PY  - 2018
ER  - 

TY  - JOUR
TI  - WORLD TRANSPLANT CONGRESS 2006 POSTER ABSTRACTS
JO  - American Journal of Transplantation
VL  - 6
IS  - s2
SN  - 1600-6135
UR  - https://doi.org/10.1111/j.1600-6143.2006.01447.x
DO  - doi:10.1111/j.1600-6143.2006.01447.x
SP  - 473
EP  - 1061
PY  - 2006
ER  - 

TY  - JOUR
TI  - 2014 Inflammatory Neuropathy Consortium of the Peripheral Nerve Society
JO  - Journal of the Peripheral Nervous System
JA  - J Peripher Nerv Syst
VL  - 19
IS  - 3
SN  - 1085-9489
UR  - https://doi.org/10.1111/jns.12083
DO  - doi:10.1111/jns.12083
SP  - 250
EP  - 289
PY  - 2014
ER  - 

TY  - JOUR
TI  - Plenary session (ACR)
JO  - Arthritis & Rheumatism
JA  - Arthritis & Rheumatism
VL  - 43
IS  - S9
SN  - 0004-3591
UR  - https://doi.org/10.1002/art.1780432008
DO  - doi:10.1002/art.1780432008
SP  - S115
EP  - S408
PY  - 2000
ER  - 

TY  - JOUR
AU  - Colvin, M.
AU  - Smith, J. M.
AU  - Hadley, N.
AU  - Skeans, M. A.
AU  - Uccellini, K.
AU  - Lehman, R.
AU  - Robinson, A. M.
AU  - Israni, A. K.
AU  - Snyder, J. J.
AU  - Kasiske, B. L.
TI  - OPTN/SRTR 2017 Annual Data Report: Heart
JO  - American Journal of Transplantation
JA  - Am J Transplant
VL  - 19
IS  - S2
SN  - 1600-6135
UR  - https://doi.org/10.1111/ajt.15278
DO  - doi:10.1111/ajt.15278
SP  - 323
EP  - 403
KW  - End-stage heart failure
KW  - heart transplant
KW  - transplant outcomes
KW  - ventricular assist device
PY  - 2019
AB  - Abstract In 2017, 3273 heart transplants were performed in the United States. New listings continued to increase, and 3769 new adults were listed for heart transplant in 2017. Over the past decade, posttransplant mortality has declined. The number of new pediatric listings increased over the past decade, as did the number of pediatric heart transplants, although some fluctuation has occurred more recently. New listings for pediatric heart transplants increased from 481 in 2007 to 623 in 2017. The number of pediatric heart transplants performed each year increased from 330 in 2007 to 432 in 2017, slightly fewer than in 2016. Short-term and long-term mortality improved. Among pediatric patients who underwent transplant between 2015-2016, 4.8% had died by 6 months and 6.2% by 1 year.
ER  - 

TY  - JOUR
TI  - Saturday, 7 July: Posters
JO  - Fundamental & Clinical Pharmacology
VL  - 15
IS  - S1
SN  - 0767-3981
UR  - https://doi.org/10.1111/j.1472-8206.2001.00012.x
DO  - doi:10.1111/j.1472-8206.2001.00012.x
SP  - 12
EP  - 51
PY  - 2001
ER  - 

TY  - JOUR
TI  - 38th Annual Meeting of the Arbeitsgemeinschaft Dermatologische Forschung (ADF)
JO  - Experimental Dermatology
VL  - 20
IS  - 2
SN  - 0906-6705
UR  - https://doi.org/10.1111/j.1600-0625.2010.01228.x
DO  - doi:10.1111/j.1600-0625.2010.01228.x
SP  - 162
EP  - 216
PY  - 2011
ER  - 

AU  - Dutta, Anand S.
C7  - pp. 1-80
TI  - Discovery of New Medicines
SN  - 9781405180351
UR  - https://doi.org/10.1002/9781444317800.ch1
DO  - doi:10.1002/9781444317800.ch1
SP  - 1-80
KW  - discovery of new medicines
KW  - understanding disease processes and mechanisms in controlling disease
KW  - severe acute respiratory syndrome (SARS)
KW  - new infectious diseases - hepatitis C, human herpes virus-6, -7 and -8 and bird flu (H5N1 virus)
KW  - underlying causes of diseases - selective and less toxic drugs
KW  - market needs and changing disease patterns
KW  - new technology impact on drug discovery
KW  - combinatorial chemistry and high-throughput screening
KW  - enzymes and enzyme inhibitors
KW  - DNA and RNA based therapeutics
PY  - 2011
AB  - Summary This chapter contains sections titled: Introduction Market needs and changing disease patterns Medicines marketed in the years 2004?2007 Historical aspects Impact of new technology on drug discovery Examples of drug discovery Enzymes and enzyme inhibitors Protein?protein interaction inhibitors Protein antibody and vaccine therapeutics DNA and RNA based therapeutics Conclusions References
ER  - 

TY  - JOUR
TI  - ACR/ARHP scientific abstracts
JO  - Arthritis & Rheumatism
JA  - Arthritis & Rheumatism
VL  - 42
IS  - S9
SN  - 9781405180351
UR  - https://doi.org/10.1002/art.1780422107
DO  - doi:10.1002/art.1780422107
SP  - S71
EP  - S407
PY  - 1999
ER  - 

TY  - JOUR
TI  - Poster Presentation Abstracts
JO  - International Journal of Rheumatic Diseases
JA  - Int J Rheum Dis
VL  - 21
IS  - S1
SN  - 9781405180351
UR  - https://doi.org/10.1111/1756-185X.13361
DO  - doi:10.1111/1756-185X.13361
SP  - 23
EP  - 236
PY  - 2018
ER  - 

TY  - JOUR
AU  - Lombard Ph.D., Julian H.
TI  - Abstracts for the 8th World Congress for Microcirculation August 15-19, 2007 Milwaukee, Wisconsin, USA
JO  - Microcirculation
JA  - Microcirculation
VL  - 14
IS  - 4‐5
SN  - 9781405180351
UR  - https://doi.org/10.1080/10739680701413573
DO  - doi:10.1080/10739680701413573
SP  - 439
EP  - 569
PY  - 2007
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - APMIS
VL  - 117
IS  - s127
SN  - 9781405180351
UR  - https://doi.org/10.1111/j.1600-0463.2009.02504.x
DO  - doi:10.1111/j.1600-0463.2009.02504.x
SP  - 67
EP  - 180
PY  - 2009
ER  - 

TY  - JOUR
TI  - Cartilage metabolism and cell based therapiesfor tissue regeneration
JO  - International Journal of Experimental Pathology
VL  - 90
IS  - 2
SN  - 9781405180351
UR  - https://doi.org/10.1111/j.1365-2613.2008.00644.x
DO  - doi:10.1111/j.1365-2613.2008.00644.x
SP  - A85
EP  - A139
PY  - 2009
ER  - 

TY  - JOUR
TI  - POSTER SESSIONS
JO  - Allergy
VL  - 63
IS  - s88
SN  - 9781405180351
UR  - https://doi.org/10.1111/j.1398-9995.2008.01760.x
DO  - doi:10.1111/j.1398-9995.2008.01760.x
SP  - 158
EP  - 611
PY  - 2008
ER  - 

TY  - JOUR
TI  - Poster Presentations
JO  - Journal of Gastroenterology and Hepatology
JA  - J Gastroenterol Hepatol
VL  - 27
IS  - S5
SN  - 9781405180351
UR  - https://doi.org/10.1111/jgh.12006
DO  - doi:10.1111/jgh.12006
SP  - 59
EP  - 438
PY  - 2012
ER  - 

TY  - JOUR
AU  - Valapour, M.
AU  - Lehr, C. J.
AU  - Skeans, M. A.
AU  - Smith, J. M.
AU  - Carrico, R.
AU  - Uccellini, K.
AU  - Lehman, R.
AU  - Robinson, A.
AU  - Israni, A. K.
AU  - Snyder, J. J.
AU  - Kasiske, B. L.
TI  - OPTN/SRTR 2016 Annual Data Report: Lung
JO  - American Journal of Transplantation
JA  - Am J Transplant
VL  - 18
IS  - S1
SN  - 9781405180351
UR  - https://doi.org/10.1111/ajt.14562
DO  - doi:10.1111/ajt.14562
SP  - 363
EP  - 433
KW  - End-stage lung disease
KW  - LAS
KW  - lung allocation score
KW  - lung transplant
KW  - organ allocation
KW  - revised lung allocation score
KW  - transplant outcomes
PY  - 2018
AB  - Abstract In 2016, 2692 candidates aged 12 years or older were added to the lung transplant waiting list; 2345 transplants were performed, the largest number of any prior year. The median waiting time for listed candidates in 2016 was 2.5 months, and waiting times were shortest for group D candidates. The transplant rate increased to 191.9 transplants per 100 waitlist years in 2016, with a slight decrease in waitlist mortality to 15.1 deaths per 100 waitlist years. Short-term survival continued to improve, with a 6-month death rate of 6.6% and a 1-year death rate of 10.8% among recipients in 2015 compared with 8.0% and 13.3%, respectively, among recipients in 2014. Long-term survival rates remained unchanged; 55.6% of recipients were alive at 5 years. In 2016, 23 new candidates aged 0-11 years were added to the waiting list and 16 lung transplants were performed. Incidence of posttransplant mortality for lung transplant recipients aged 0-11 years who underwent transplant in 2014-2015 was 13.8% at 6 months and 19.6% at 1 year. Changes in waitlist and transplant demographic features continued to evolve following implementation of the revised lung allocation score in 2015. Some early trends that may be attributable to the revised LAS are shorter waiting times, stabilization of the number of group D candidates listed for transplant, and convergence of LAS with lower prevalence of extremely high scores.
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - Pigment Cell Research
VL  - 17
IS  - 5
SN  - 9781405180351
UR  - https://doi.org/10.1111/j.1600-0749.2004.00187_2.x
DO  - doi:10.1111/j.1600-0749.2004.00187_2.x
SP  - 563
EP  - 603
PY  - 2004
ER  - 

TY  - JOUR
TI  - ASBMR 25th Annual Meeting F002–F482
JO  - Journal of Bone and Mineral Research
JA  - J Bone Miner Res
VL  - 18
IS  - S1
SN  - 9781405180351
UR  - https://doi.org/10.1002/jbmr.5650181303
DO  - doi:10.1002/jbmr.5650181303
SP  - S56
EP  - S100
PY  - 2003
ER  - 

TY  - JOUR
TI  - Oral Abstracts
JO  - Mycoses
VL  - 55
IS  - s4
SN  - 9781405180351
UR  - https://doi.org/10.1111/j.1439-0507.2012.02205.x
DO  - doi:10.1111/j.1439-0507.2012.02205.x
SP  - 57
EP  - 94
PY  - 2012
ER  - 
